Pay in 4 interest-free payments of $7.28 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Despite years of safe compounding, established protocols, and satisfied patients, Category 2 designation meant immediate cessation
Some cease peptide prescribing entirely rather than risk regulatory violation
The milligrams on the label are the milligrams in the vial
Whether youre a patient who just learned your compound got banned, a provider navigating compliance, or someone researching peptides wondering whats actually legal - this should answer your questions. TL;DR: Category 2 banned 17 peptides in Oct 2023 - no compounding regardless of prescription GLP-1 compounding ended after shortage resolution (Feb 2025) Research peptides exist in a gray zone
US$ 24.48
US$ 23.13
US$ 22.94
US$ 25.23
US$ 27.41
US$ 28.20
